The DOI matches its Crossref record; 284 of the 284 references it cites were found in a registry or an index.
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Diagnostic and Statistical Manual of Mental Disorders, 5th ed.
Carter, M. J. (2014) · Therapeutic Recreation Journal · Cited by 15,167
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 11,772
(2007) · Cited by 6,530
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L. F., Gautvik, V. T., Bartlett, F. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.322 · Cited by 3,878 · cited 1×
“They are produced exclusively by a population of neurons in the lateral hypothalamic area (de Lecea et al., 1998; Sakurai et al., 1998).”
BackgroundEpidemiology of insomnia: what we know and what we still need to learn
Ohayon, M. M. (2002) · Sleep Medicine Reviews · doi:10.1053/smrv.2002.0186 · Cited by 3,743 · cited 2×
“The prevalence rate of insomnia in the general population has been estimated as low as 5% to as high as 50% (Ohayon, 2002; Morin and Jarrin, 2013).”
BackgroundA review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
Narcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095
Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P. J., Nishino, S., & Mignot, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81965-0 · Cited by 2,613
Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults
Schutte-Rodin, S., Broch, L., Buysse, D., Dorsey, C., & Sateia, M. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27286 · Cited by 1,943 · cited 2×
“Similarly, guidelines for the treatment of chronic insomnia report insufficient evidence for atypical antipsychotics as first-line therapy (Schutte-Rodin et al., 2008), but state that the medications may be suitable for patients with comorbid insomnia who may benefit from the primary action of these drugs as well as f…”
BackgroundThe sleep switch: hypothalamic control of sleep and wakefulness
Saper, C. B., Chou, T. C., & Scammell, T. E. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02002-6 · Cited by 1,656
Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6470 · Cited by 1,519
Adenosine Receptors as Therapeutic Targets
Jacobson, K. A., & Gao, Z.-G. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1983 · Cited by 1,431 · cited 1×
“Other receptors involved in sleep, but which remain to be pharmacologically exploited, include the adenosine A1 and A2 receptors (Jacobson and Gao, 2006).”
BackgroundGenetic Ablation of Orexin Neurons in Mice Results in Narcolepsy, Hypophagia, and Obesity
Hara, J., Beuckmann, C. T., Nambu, T., Willie, J. T., Chemelli, R. M., Sinton, C. M., Sugiyama, F., Yagami, K.-I., Goto, K., Yanagisawa, M., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00293-8 · Cited by 1,403
Orexin A activates locus coeruleus cell firing and increases arousal in the rat
Hagan, J. J., Leslie, R. A., Patel, S., Evans, M. L., Wattam, T. A., Holmes, S., Benham, C. D., Taylor, S. G., Routledge, C., Hemmati, P., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10911 · Cited by 1,234
Mander, B. A., Winer, J. R., & Walker, M. P. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.004 · Cited by 1,185
The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2δ Subunit of a Calcium Channel
Gee, N. S., Brown, J. P., Dissanayake, V. U. K., Offord, J., Thurlow, R., & Woodruff, G. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5768 · Cited by 1,181
Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine
Bymaster, F. P., Calligaro, D. O., Falcone, J. F., Marsh, R. D., Moore, N. A., Tye, N. C., Seeman, P., & Wong, D. T. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00129-n · Cited by 1,062
GABAA receptors: Subtypes provide diversity of function and pharmacology
Olsen, R. W., & Sieghart, W. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.045 · Cited by 982
Neural Circuitry of Wakefulness and Sleep
Scammell, T. E., Arrigoni, E., & Lipton, J. O. (2017) · Neuron · doi:10.1016/j.neuron.2017.01.014 · Cited by 966
Pharmacological profile of antidepressants and related compounds at human monoamine transporters
Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939
The role of histamine and the tuberomamillary nucleus in the nervous system
Haas, H., & Panula, P. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1034 · Cited by 929
De Gennaro, L., & Ferrara, M. (2003) · Sleep Medicine Reviews · doi:10.1053/smrv.2002.0252 · Cited by 922
Morin, C. M., & Jarrin, D. C. (2022) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2022.03.003 · Cited by 907
Calabrese, J. R., Keck, P. E., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E., Mullen, J., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1351 · Cited by 883
Pompeiano, M., Palacios, J. M., & Mengod, G. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90223-2 · Cited by 881
A Review of the Pharmacological and Clinical Profile of Mirtazapine
Anttila, S. A. K., & Leinonen, E. V. J. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00198.x · Cited by 795
Insomnia and daytime cognitive performance: A meta-analysis
Fortier-Brochu, É., Beaulieu-Bonneau, S., Ivers, H., & Morin, C. M. (2012) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2011.03.008 · Cited by 753
Steriade, M., Contreras, D., Curro Dossi, R., & Nunez, A. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-08-03284.1993 · Cited by 722
Cloning and Functional Expression of the Human Histamine H3Receptor
Lovenberg, T. W., Roland, B. L., Wilson, S. J., Jiang, X., Pyati, J., Huvar, A., Jackson, M. R., & Erlander, M. G. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.6.1101 · Cited by 696
Tricyclic antidepressant pharmacology and therapeutic drug interactions updated
Gillman, P. K. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707253 · Cited by 694
The mechanisms of action of gabapentin and pregabalin
SILLS, G. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.11.003 · Cited by 671
Distinct Narcolepsy Syndromes in Orexin Receptor-2 and Orexin Null Mice
Willie, J. T., Chemelli, R. M., Sinton, C. M., Tokita, S., Williams, S. C., Kisanuki, Y. Y., Marcus, J. N., Lee, C., Elmquist, J. K., Kohlmeier, K. A., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00330-1 · Cited by 645
Neuronal Plasticity in Thalamocortical Networks during Sleep and Waking Oscillations
Steriade, M., & Timofeev, I. (2003) · Neuron · doi:10.1016/s0896-6273(03)00065-5 · Cited by 643
Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine
Huang, Z.-L., Qu, W.-M., Eguchi, N., Chen, J.-F., Schwarzschild, M. A., Fredholm, B. B., Urade, Y., & Hayaishi, O. (2005) · Nature Neuroscience · doi:10.1038/nn1491 · Cited by 640
A manual of Standardized Terminology
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 632
Oda, T., Morikawa, N., Saito, Y., Masuho, Y., & Matsumoto, S.-I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006480200 · Cited by 608
Binding of antipsychotic drugs to human brain receptors
Richelson, E., & Souder, T. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00911-5 · Cited by 607
Steriade, M., Contreras, D., & Nuiiez, A. (1993) · Cited by 594
From waking to sleeping: neuronal and chemical substrates
Jones, B. E. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.09.009 · Cited by 575
Taylor, C. P., Angelotti, T., & Fauman, E. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.09.008 · Cited by 565
Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist
Kato, K., Hirai, K., Nishiyama, K., Uchikawa, O., Fukatsu, K., Ohkawa, S., Kawamata, Y., Hinuma, S., & Miyamoto, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.007 · Cited by 539
Jakab, R. L., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.735 · Cited by 536
Michelson, D., Snyder, E., Paradis, E., Chengan-Liu, M., Snavely, D. B., Hutzelmann, J., Walsh, J. K., Krystal, A. D., Benca, R. M., Cohn, M., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70053-5 · Cited by 519
Millan, M. J., Gobert, A., Lejeune, F., Dekeyne, A., Newman-Tancredi, A., Pasteau, V., Rivet, J.-M., & Cussac, D. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051797 · Cited by 516
Afferents to the Ventrolateral Preoptic Nucleus
Chou, T. C., Bjorkum, A. A., Gaus, S. E., Lu, J., Scammell, T. E., & Saper, C. B. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00977.2002 · Cited by 494
Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders
Ferracioli-Oda, E., Qawasmi, A., & Bloch, M. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063773 · Cited by 483
Quality of life in people with insomnia.
Zammit, G. K., Weiner, J., Damato, N., Sillup, G. P., & McMillan, C. A. (1999) · PubMed · Cited by 467
Nierenberg, A. A., Husain, M. M., Trivedi, M. H., Fava, M., Warden, D., Wisniewski, S. R., Miyahara, S., & Rush, A. J. (2010) · Psychological Medicine · doi:10.1017/s0033291709006011 · Cited by 458
The diagnosis and management of benzodiazepine dependence
Ashton, H. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165594.60434.84 · Cited by 455
Hassani, O. K., Lee, M. G., & Jones, B. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811400106 · Cited by 451
An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomnia
ERMAN, M., SEIDEN, D., ZAMMIT, G., SAINATI, S., & ZHANG, J. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2005.09.004 · Cited by 434
The involvement of dopamine in the modulation of sleep and waking
Monti, J. M., & Monti, D. (2007) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2006.08.003 · Cited by 415
Benzodiazepine Use and the Risk of Motor Vehicle Crash in the Elderly
Hemmelgarn, B. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550010041037 · Cited by 395
Antidepressants and Sleep: A Qualitative Review of the Literature
Wilson, S., & Argyropoulos, S. (2005) · Drugs · doi:10.2165/00003495-200565070-00003 · Cited by 392
Clinical Pharmacokinetics of Quetiapine: An Atypical Antipsychotic
DeVane, C. L., & Nemeroff, C. B. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140070-00003 · Cited by 386
Cox, C. D., Breslin, M. J., Whitman, D. B., Schreier, J. D., McGaughey, G. B., Bogusky, M. J., Roecker, A. J., Mercer, S. P., Bednar, R. A., Lemaire, W., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100541c · Cited by 379
Melatonin receptors in humans: biological role and clinical relevance
Ekmekcioglu, C. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.01.002 · Cited by 370
Nakamura, T., Uramura, K., Nambu, T., Yada, T., Goto, K., Yanagisawa, M., & Sakurai, T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02555-5 · Cited by 351
Noradrenergic modulation of wakefulness/arousal
Berridge, C. W., Schmeichel, B. E., & España, R. A. (2012) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2011.12.003 · Cited by 346
Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Adults with Primary Insomnia
Roth, T., Rogowski, R., Hull, S., Schwartz, H., Koshorek, G., Corser, B., Seiden, D., & Lankford, A. (2007) · Sleep · doi:10.1093/sleep/30.11.1555 · Cited by 338
McElroy, S. L., Weisler, R. H., Chang, W., Olausson, B., Paulsson, B., Brecher, M., Agambaram, V., Merideth, C., Nordenhem, A., Young, A. H., et al. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04942gre · Cited by 328
Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant
Herring, W. J., Snyder, E., Budd, K., Hutzelmann, J., Snavely, D., Liu, K., Lines, C., Roth, T., & Michelson, D. (2012) · Neurology · doi:10.1212/wnl.0b013e31827688ee · Cited by 322
Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis
Banasr, M., Soumier, A., Hery, M., Mocaër, E., & Daszuta, A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.025 · Cited by 318 · cited 1×
“…in the frontal cortex, without an effect on serotonin (European Medicines Agency, 2008a); like many other antidepressants, agomelatine administration is associated with increased expression of brain-derived neurotrophic factormRNA and enhanced neurogenesis in the hippocampus (Banasr et al., 2006).”
BackgroundA Review of the Evidence for the Efficacy and Safety of Trazodone in Insomnia
Mendelson, W. B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0409 · Cited by 308
Fossum, I. N., Nordnes, L. T., Storemark, S. S., Bjorvatn, B., & Pallesen, S. (2014) · Behavioral Sleep Medicine · doi:10.1080/15402002.2013.819468 · Cited by 306
National Use of Prescription Medications for Insomnia: NHANES 1999-2010
Bertisch, S. M., Herzig, S. J., Winkelman, J. W., & Buettner, C. (2014) · Sleep · doi:10.5665/sleep.3410 · Cited by 305
Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials
Herring, W. J., Connor, K. M., Ivgy-May, N., Snyder, E., Liu, K., Snavely, D. B., Krystal, A. D., Walsh, J. K., Benca, R. M., Rosenberg, R., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.10.003 · Cited by 300
Metabolism of Tricyclic Antidepressants
Rudorfer, M. V., & Potter, W. Z. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006949816036 · Cited by 296
Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease
Paus, S., Brecht, H. M., Köster, J., Seeger, G., Klockgether, T., & Wüllner, U. (2003) · Movement Disorders · doi:10.1002/mds.10417 · Cited by 295
Lockley, S. W., Dressman, M. A., Licamele, L., Xiao, C., Fisher, D. M., Flynn-Evans, E. E., Hull, J. T., Torres, R., Lavedan, C., & Polymeropoulos, M. H. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60031-9 · Cited by 294
Daytime symptoms in primary insomnia: A prospective analysis using ecological momentary assessment
Buysse, D. J., Thompson, W., Scott, J., Franzen, P. L., Germain, A., Hall, M., Moul, D. E., Nofzinger, E. A., & Kupfer, D. J. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2006.10.006 · Cited by 289
Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission
Snyder, G. L., Vanover, K. E., Zhu, H., Miller, D. B., O’Callaghan, J. P., Tomesch, J., Li, P., Zhang, Q., Krishnan, V., Hendrick, J. P., et al. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3704-1 · Cited by 289
Health economics of insomnia treatments: The return on investment for a good night's sleep
Wickwire, E. M., Shaya, F. T., & Scharf, S. M. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.11.004 · Cited by 287
Sleep Neurobiology from a Clinical Perspective
(2011) · Sleep · doi:10.5665/sleep.1112 · Cited by 277
Neuronal ensembles sufficient for recovery sleep and the sedative actions of α2 adrenergic agonists
Zhang, Z., Ferretti, V., Güntan, İ., Moro, A., Steinberg, E. A., Ye, Z., Zecharia, A. Y., Yu, X., Vyssotski, A. L., Brickley, S. G., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3957 · Cited by 275
Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist
Winrow, C. J., Gotter, A. L., Cox, C. D., Doran, S. M., Tannenbaum, P. L., Breslin, M. J., Garson, S. L., Fox, S. V., Harrell, C. M., Stevens, J., et al. (2011) · Journal of Neurogenetics · doi:10.3109/01677063.2011.566953 · Cited by 269
Differential Roles of Orexin Receptor-1 and -2 in the Regulation of Non-REM and REM Sleep
Mieda, M., Hasegawa, E., Kisanuki, Y. Y., Sinton, C. M., Yanagisawa, M., & Sakurai, T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6506-10.2011 · Cited by 267
Mechanism of Action of Trazodone:a Multifunctional Drug
Stahl, S. M. (2009) · CNS Spectrums · doi:10.1017/s1092852900024020 · Cited by 266
Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia
Roth, T., Seiden, D., Sainati, S., Wang-Weigand, S., Zhang, J., & Zee, P. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2006.01.003 · Cited by 265
Modulation of neurotransmitter release via histamine H3heteroreceptors
Schlicker, E., Malinowska, B., Kathmann, M., & Göthert, M. (1994) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.1994.tb00789.x · Cited by 263
LEMOINE, P., NIR, T., LAUDON, M., & ZISAPEL, N. (2007) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2007.00613.x · Cited by 261
Kasper, S., Hajak, G., Wulff, K., Hoogendijk, W. J. G., Montejo, A. L., Smeraldi, E., Rybakowski, J. K., Quera-Salva, M.-A., Wirz-Justice, A. M., Picarel-Blanchot, F., et al. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05347blu · Cited by 257
Citrome, L. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12568 · Cited by 249
De Sarro, G. B., Ascioti, C., Froio, F., Libri, V., & Nisticò, G. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11220.x · Cited by 242
Wade, A. G., Ford, I., Crawford, G., McMahon, A. D., Nir, T., Laudon, M., & Zisapel, N. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x233098 · Cited by 237
The American Psychiatric Publishing textbook of psychopharmacology
(2010) · Choice Reviews Online · doi:10.5860/choice.47-4164 · Cited by 233
The clinical and forensic toxicology of Z-drugs
Gunja, N. (2013) · Journal of Medical Toxicology · doi:10.1007/s13181-013-0292-0 · Cited by 230
Dugovic, C., Shelton, J. E., Aluisio, L. E., Fraser, I. C., Jiang, X., Sutton, S. W., Bonaventure, P., Yun, S., Li, X., Lord, B., et al. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.152009 · Cited by 230
Trazodone for antidepressant-associated insomnia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.1069 · Cited by 227
Tsunematsu, T., Ueno, T., Tabuchi, S., Inutsuka, A., Tanaka, K. F., Hasuwa, H., Kilduff, T. S., Terao, A., & Yamanaka, A. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.5344-13.2014 · Cited by 220
Rajaratnam, S. M., Polymeropoulos, M. H., Fisher, D. M., Roth, T., Scott, C., Birznieks, G., & Klerman, E. B. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61812-7 · Cited by 215
Ford, E. S., Wheaton, A. G., Cunningham, T. J., Giles, W. H., Chapman, D. P., & Croft, J. B. (2014) · Sleep · doi:10.5665/sleep.3914 · Cited by 213
Hindmarch, I., Dawson, J., & Stanley, N. (2005) · Sleep · doi:10.1093/sleep/28.2.187 · Cited by 209
Morin, C. M., & Jarrin, D. C. (2013) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2013.05.002 · Cited by 207
Histamine receptors in the CNS as targets for therapeutic intervention
Passani, M. B., & Blandina, P. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.01.003 · Cited by 206
The American Psychiatric Publishing Textbook of Psychopharmacology
Schatzberg, A. F., & Nemeroff, C. B. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585623860 · Cited by 202
Smith, M. T., & Wegener, S. T. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11409 · Cited by 200
Qu, W.-M., Xu, X.-H., Yan, M.-M., Wang, Y.-Q., Urade, Y., & Huang, Z.-L. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4936-09.2010 · Cited by 199
Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis
Kuriyama, A., Honda, M., & Hayashino, Y. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2013.11.788 · Cited by 198
Evaluation of the Efficacy and Safety of Ramelteon in Subjects with Chronic Insomnia
Zammit, G., Erman, M., Wang-Weigand, S., Sainati, S., Zhang, J., & Roth, T. (2007) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26914 · Cited by 197
Krystal, A. D., Durrence, H. H., Scharf, M., Jochelson, P., Rogowski, R., Ludington, E., & Roth, T. (2010) · Sleep · doi:10.1093/sleep/33.11.1553 · Cited by 193
Gabapentin Increases Slow‐wave Sleep in Normal Adults
Foldvary‐Schaefer, N., De Leon Sanchez, I., Karafa, M., Mascha, E., Dinner, D., & Morris, H. H. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.21002.x · Cited by 187
Huang, Z.-L., Mochizuki, T., Qu, W.-M., Hong, Z.-Y., Watanabe, T., Urade, Y., & Hayaishi, O. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600451103 · Cited by 184
Portas, C., Thakkar, M., Rainnie, D., & McCarley, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-08-02820.1996 · Cited by 183
霊長類大脳皮質の5‐ヒドロキシトリプタミン2Aセロトニン受容体 錐体細胞先端樹状突起での幻覚剤及び抗精神病剤の作用部位
Jakab, R. L., & Goldman‐Rakic, P. S. (1998) · Cited by 182
Sleep EEG Power Spectra, Insomnia, and Chronic Use of Benzodiazepines
Bastien, C. H., LeBlanc, M., Carrier, J., & Morin, C. M. (2003) · Sleep · doi:10.1093/sleep/26.3.313 · Cited by 181
Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain
Lacoste, B., Angeloni, D., Dominguez‐Lopez, S., Calderoni, S., Mauro, A., Fraschini, F., Descarries, L., & Gobbi, G. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12224 · Cited by 181
Self-citationRegulation of the dopamine transporter: Aspects relevant to psychostimulant drugs of abuse
Schmitt, K. C., & Reith, M. E. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05148.x · Cited by 180
Sleep-promoting properties of quetiapine in healthy subjects
Cohrs, S., Rodenbeck, A., Guan, Z., Pohlmann, K., Jordan, W., Meier, A., & R�ther, E. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1759-5 · Cited by 180
Brower, K. J., Myra Kim, H., Strobbe, S., Karam‐Hage, M. A., Consens, F., & Zucker, R. A. (2008) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00706.x · Cited by 179
Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity
Vaishnavi, S. N., Nemeroff, C. B., Plott, S. J., Rao, S. G., Kranzler, J., & Owens, M. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.07.006 · Cited by 178
Theobald, D. E., Kirsh, K. L., Holtsclaw, E., Donaghy, K., & Passik, S. D. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00381-0 · Cited by 178
Wade, A. G., Ford, I., Crawford, G., McConnachie, A., Nir, T., Laudon, M., & Zisapel, N. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-51 · Cited by 178
In the Zzz Zone: The Effects of Z-Drugs on Human Performance and Driving
Gunja, N. (2013) · Journal of Medical Toxicology · doi:10.1007/s13181-013-0294-y · Cited by 177
Boutrel, B., Franc, B., Hen, R., Hamon, M., & Adrien, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03204.1999 · Cited by 177
Laudon, M., G Wade, A., Farmer, M., Harari, G., Fund, N., Nir, T., Frydman-Marom, A., & Zisapel, N. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s65625 · Cited by 173
Camargos, E. F., Louzada, L. L., Quintas, J. L., Naves, J. O. S., Louzada, F. M., & Nóbrega, O. T. (2014) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.12.174 · Cited by 170
Popa, D., Léna, C., Fabre, V., Prenat, C., Gingrich, J., Escourrou, P., Hamon, M., & Adrien, J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1724-05.2005 · Cited by 170
Essential roles of CKIδ and CKIε in the mammalian circadian clock
Lee, H., Chen, R., Lee, Y., Yoo, S., & Lee, C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906651106 · Cited by 168
The Pharmacology and Mechanisms of Action of New Generation, Non-Benzodiazepine Hypnotic Agents
Sanger, D. J. (2004) · CNS Drugs · doi:10.2165/00023210-200418001-00004 · Cited by 168
Gobbi, G., Murphy, D. L., Lesch, K.-P., & Blier, P. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38843-3 · Cited by 168
Self-citationBoutrel, B., Monaca, C., Hen, R., Hamon, M., & Adrien, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04686.2002 · Cited by 166
Winokur, A., DeMartinis, N. A., McNally, D. P., Gary, E. M., Cormier, J. L., & Gary, K. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1013 · Cited by 165 · cited 3×
“…et al., 2000); one randomized trial (N = 19) comparing mirtazapine to fluoxetine in patients diagnosed with major depressive disorder and insomnia (Winokur et al., 2003); one open-label study (N = 53) in patients with cancer and comorbid MDD, anxiety disorders, or adjustment disorder (Cankurtaran…”
BackgroundInfluentialMayer, G., Wang-Weigand, G., Roth‐Schechter, B. F., Lehmann, R., Staner, C., & Partinen, M. (2009) · SLEEP · doi:10.1093/sleep/32.3.351 · Cited by 165
Searching for perfect sleep: the continuing evolution of GABA A receptor modulators as hypnotics
Nutt, D. J., & Stahl, S. M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109106927 · Cited by 163
Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases
Pérez, D. I., Gil, C., & Martínez, A. (2010) · Medicinal Research Reviews · doi:10.1002/med.20207 · Cited by 163
Sun, H., Kennedy, W. P., Wilbraham, D., Lewis, N., Calder, N., Li, X., Ma, J., Yee, K. L., Ermlich, S., Mangin, E., et al. (2013) · SLEEP · doi:10.5665/sleep.2386 · Cited by 162
The functional significance of K-complexes
Amzica, F., & Steriade, M. (2002) · Sleep Medicine Reviews · doi:10.1053/smrv.2001.0181 · Cited by 161
A Comparison of Venlafaxine, Trazodone, and Placebo in Major Depression
CUNNINGHAM, L. A., BORISON, R. L., CARMAN, J. S., CHOUINARD, G., CROWDER, J. E., DIAMOND, B. I., FISCHER, D. E., & HEARST, E. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199404000-00003 · Cited by 159
Discovery and development of orexin receptor antagonists as therapeutics for insomnia
Winrow, C. J., & Renger, J. J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12261 · Cited by 158
Takahashi, K., Suwa, H., Ishikawa, T.-O., & Kotani, H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15784 · Cited by 155
Soldatos, C. R., Dikeos, D. G., & Whitehead, A. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199909000-00004 · Cited by 154
Benzodiazepine Use as a Cause of Cognitive Impairment in Elderly Hospital Inpatients
Foy, A., O'Connell, D., Henry, D. A., Kelly, J., Cocking, S., & Halliday, J. A. (1995) · The Journals of Gerontology Series A · doi:10.1093/gerona/50a.2.m99 · Cited by 154
Sleep and its homeostatic regulation in mice lacking the adenosine A 1 receptor
Stenberg, D., Litonius, E. S., Halldner, L., Johansson, B. A., Fredholm, B. B., & Porkka‐Heiskanen, T. (2003) · Journal of Sleep Research · doi:10.1046/j.0962-1105.2003.00367.x · Cited by 152
Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors
Yin, J., Babaoglu, K., Brautigam, C. A., Clark, L. D., Shao, Z., Scheuermann, T. H., Harrell, C. M., Gotter, A. L., Roecker, A. J., Winrow, C. J., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3183 · Cited by 148
Szabo, S. T., & Blier, P. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03121-3 · Cited by 146
Albarazanji, K. A., Wilson, S., Baker, J., Jessop, D. S., & Harbuz, M. S. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2001.00655.x · Cited by 146
Antagonism of serotonergic 5‐HT2A/2Creceptors: mutual improvement of sleep, cognition and mood?
Landolt, H., & Wehrle, R. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06718.x · Cited by 142
Mechanisms of action of gabapentin.
Cp, T. (1997) · PubMed · Cited by 142
Krystal, A. D., Lankford, A., Durrence, H. H., Ludington, E. A., Jochelson, P., Rogowski, R., & Roth, T. G. (2011) · SLEEP · doi:10.5665/sleep.1294 · Cited by 141
Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT2C receptors in vivo
Sharpley, A. L., Vassallo, C. M., & Cowen, P. J. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00273-5 · Cited by 141
Tricyclic antidepressants and histamine H1 receptors.
Richelson, E. (1979) · PubMed · Cited by 138
Mets, M. A. J., de Vries, J. M., Domis, L. M. D. S., Volkerts, E. R., Olivier, B., & Verster, J. C. (2011) · SLEEP · doi:10.5665/sleep.1272 · Cited by 136
Minireview: Sleep regulation in adenosine A2Areceptor-deficient mice
Urade, Y., Eguchi, N., Qu, W., Sakata, M., Huang, Z., Chen, J., Schwarzschild, M. A., Fink, J. S., & Hayaishi, O. (2003) · Neurology · doi:10.1212/01.wnl.0000095222.41066.5e · Cited by 136
Aslan, S., Isik, E., & Cosar, B. (2002) · Sleep · doi:10.1093/sleep/25.6.666 · Cited by 135
Luthringer, R., Muzet, M., Zisapel, N., & Staner, L. (2009) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32832e9b08 · Cited by 135
The Psychopharmacology of Aggressive Behavior: A Translational Approach Part 1 Neurobiology
Comai, S., Tau, M., & Gobbi, G. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31823f8770 · Cited by 133
Self-citationQuetiapine for insomnia: A review of the literature
Anderson, S. L., & Griend, J. P. V. (2014) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp130221 · Cited by 133
The effects of trazodone on sleep in patients treated with stimulant antidepressants
Kaynak, H., Kaynak, D., Gözükırmızı, E., & Guilleminault, C. (2003) · Sleep Medicine · doi:10.1016/j.sleep.2003.06.006 · Cited by 133
Otmani, S., Demazières, A., Staner, C., Jacob, N., Nir, T., Zisapel, N., & Staner, L. (2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.980 · Cited by 133
Drugs Used to Treat Insomnia in 2002: Regulatory-Based Rather Than Evidence-Based Medicine
Walsh, J. K. (2004) · SLEEP · doi:10.1093/sleep/27.8.1441 · Cited by 128
Ochoa‐Sanchez, R., Comai, S., Lacoste, B., Bambico, F. R., Domínguez-López, S., Spadoni, G., Rivara, S., Bedini, A., Angeloni, D., FRASCHINI, F., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2676-11.2011 · Cited by 128
Self-citationDoxepin for insomnia: A systematic review of randomized placebo-controlled trials
Yeung, W.-F., Chung, K.-F., Yung, K.-P., & Ng, T. H.-Y. (2015) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2014.06.001 · Cited by 126
Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression
Kim, S., Shin, I., Kim, J. M., Kim, Y., Kim, K., Kim, K., Yang, S., & Yoon, J. (2008) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2007.01778.x · Cited by 126
Adams, K. H., Pinborg, L. H., Svarer, C., Hasselbalch, S. G., Holm, S., Haugbøl, S., Madsen, K., Frøkjær, V. G., Martiny, L., Paulson, O. B., et al. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.10.046 · Cited by 124
Winokur, A., Sateia, M. J., Hayes, J. B., Bayles-Dazet, W., MacDonald, M. M., & Gary, K. A. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00882-9 · Cited by 123
Comai, S., Tau, M., Pavlovic, Z. M., & Gobbi, G. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31824929d6 · Cited by 123
Self-citationComai, S., Ochoa‐Sanchez, R., & Gobbi, G. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.008 · Cited by 122
Self-citationNollet, M., Gaillard, P., Minier, F., Tanti, A., Belzung, C., & Leman, S. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.022 · Cited by 121
Slow wave sleep in humans: Role of 5-HT2A and 5-HT2C receptors
Sharpley, A. L., Elliott, J. M., Attenburrow, M.-J., & Cowen, P. J. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90077-9 · Cited by 121
Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia
Lemoine, P., & Zisapel, N. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.667076 · Cited by 120
Not a single but multiple populations of GABAergic neurons control sleep
Luppi, P., Peyron, C., & Fort, P. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.03.002 · Cited by 117
Friedmann, P. D., Rose, J. S., Swift, R., Stout, R. L., Millman, R. P., & Stein, M. D. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00742.x · Cited by 116
Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources.
Rotzinger, S., Fang, J., & Baker, G. B. (1998) · PubMed · Cited by 116
Effects of trazodone on the sleep of depressed subjects—a polygraphic study
Mouret, J., Lemoine, P., Minuit, M. P., Benkelfat, C., & Renardet, M. (1988) · Psychopharmacology · doi:10.1007/bf00172629 · Cited by 116
Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Elderly Patients With Primary Insomnia
Scharf, M. B., Rogowski, R., Hull, S. G., Cohn, M. A., Mayleben, D. W., Feldman, N. T., Ereshefsky, L., Lankford, A., & Roth, T. G. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1005 · Cited by 111
Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time
Wafford, K. A., & Ebert, B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2464 · Cited by 111
The Use of Trazodone as a Hypnotic: A Critical Review
JAMES, S. P., & Mendelson, W. B. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0605 · Cited by 111
Treatment Effects of Gabapentin for Primary Insomnia
Lo, H.-S., Yang, C., Lo, H. G., Lee, C., Ting, H., & Tzang, B. (2010) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181cda242 · Cited by 110
The Pharmacologic Management of SSRI-Induced Side Effects: A Survey of Psychiatrists
Dording, C., Mischoulon, D., Petersen, T., Kornbluh, R., Gordon, J., Nierenberg, A., Rosenbaum, J., & Fava, M. (2002) · Annals of Clinical Psychiatry · doi:10.3109/10401230209147450 · Cited by 109 · cited 1×
“A survey revealed that trazodone was the first-line choice of 78% or psychiatrists when prescribing medications to treat SSRI-induced insomnia (Dording et al., 2002).”
BackgroundCankurtaran, E. Ş., Özalp, E., Soygür, H., Akbıyık, D. İ., Turhan, L., & Alkış, N. (2008) · Supportive Care in Cancer · doi:10.1007/s00520-008-0425-1 · Cited by 108
The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome
Russell, I. J., Crofford, L. J., León, T., Cappelleri, J. C., Bushmakin, A. G., Whalen, E., Barrett, J. A., & Sadosky, A. (2009) · Sleep Medicine · doi:10.1016/j.sleep.2009.01.009 · Cited by 102
Le Bon, O., Murphy, J. R., Staner, L., Hoffmann, G., Kormoss, N., Kentos, M., Dupont, P., Lion, K., Pelc, I., & Verbanck, P. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000085411.08426.d3 · Cited by 102
Hartmann, E. L., & Cravens, J. (1973) · Psychopharmacology · doi:10.1007/bf00429086 · Cited by 100
Benzodiazepine use and motor vehicle accidents. Systematic review of reported association.
Thomas, R. E. (1998) · PubMed · Cited by 97
Atypical antipsychotics for insomnia: a systematic review
Thompson, W., Quay, T. A. W., Rojas‐Fernandez, C. H., Farrell, B. J., & Bjerre, L. M. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2016.04.003 · Cited by 97
(1990) · PubMed · Cited by 95
Open pilot study of gabapentin versus trazodone to treat insomnia in alcoholic outpatients
Karam‐Hage, M., & Brower, K. J. (2003) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2003.01161.x · Cited by 95
Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency
Salín-Pascual, R. J., Herrera-Estrella, M., Galicia-Polo, L., & Laurrabaquio, M. R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00372-2 · Cited by 94
Pringsheim, T. M., & Gardner, D. M. (2014) · CMAJ Open · doi:10.9778/cmajo.20140009 · Cited by 94
López‐Giménez, J. F., Mengod, G., Palacios, J. M., & Vilaró, M. T. (2001) · Synapse · doi:10.1002/syn.1095 · Cited by 93
Impact of the novel antidepressant agomelatine on disturbed sleep–wake cycles in depressed patients
Quera‐Salva, M., Lemoine, P., & Guilleminault, C. (2010) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1112 · Cited by 92
Lankford, A., Rogowski, R., Essink, B., Ludington, E. A., Durrence, H. H., & Roth, T. G. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2011.09.006 · Cited by 92
Giménez, S., Clos, S., Romero, S., Grasa, E., Morte, A., & Barbanoj, M. J. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0633-7 · Cited by 92
Bonaventure, P., Shelton, J. E., Yun, S., Nepomuceno, D. H., Sutton, S. W., Aluisio, L. E., Fraser, I. C., Lord, B., Shoblock, J. R., Welty, N., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.225466 · Cited by 91
Quera-Salva, M.-A., Hajak, G., Philip, P., Montplaisir, J., Keufer-Le Gall, S., Laredo, J., & Guilleminault, C. (2011) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328349b117 · Cited by 91
The adenosine-mediated, neuronal-glial, homeostatic sleep response
Greene, R. W., Bjorness, T. E., & Suzuki, A. (2017) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.05.015 · Cited by 88
Dose‐dependent effects of the 5‐HT1A receptor agonist 8‐OH‐DPAT on sleep and wakefulness in the rat
Monti, J. M., & Jantos, H. (1992) · Journal of Sleep Research · doi:10.1111/j.1365-2869.1992.tb00033.x · Cited by 86
Quetiapine in primary insomnia: a pilot study
Wiegand, M. H., Landry, F., Brückner, T., Pohl, C., Veselý, Z., & Jähn, T. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0968-8 · Cited by 83
Alpha 2 adrenergic receptors on GABAergic, putative sleep‐promoting basal forebrain neurons
Manns, I. D., Lee, M., Modirrousta, M., Hou, Y. P., & Jones, B. E. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02788.x · Cited by 83
Kishi, T., Matsunaga, S., & Iwata, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136910 · Cited by 82
Arbon, E. L., Knurowska, M., & Dijk, D. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581963 · Cited by 82
Quetiapine for Insomnia in Parkinson Disease
Carlos Juri, C., Chaná, P., Tapia, J., Kunstmann, C., & Parrao, T. (2005) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000174932.82134.e2 · Cited by 81
Lateral hypothalamic circuits for sleep–wake control
Yamashita, T., & Yamanaka, A. (2017) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.03.020 · Cited by 81
Baune, B. T., Caliskan, S., & Todder, D. (2006) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.817 · Cited by 79
Research works printed but not linked: 12
- Cates, 2009, Metabolic consequences of using low-dose quetiapine for insomnia in psychiatric patients, Community Ment Health J, 45, 251, 10.1007/s10597-009-9200-0 · doi:10.1007/s10597-009-9200-0
- Dhillon, 2014, Tasimelteon: first global approval, Drugs, 74, 505, 10.1007/s40265-014-0200-1 · doi:10.1007/s40265-014-0200-1
- Enomoto, 2012, Effects of mirtazapine on sleep disturbance under neuropathic pain-like state, Synapse, 66, 483, 10.1002/syn.21532 · doi:10.1002/syn.21532
- Feeney, 2009, Melatonin agonist tasimelteon improves sleep in primary insomnia characterized by difficulty falling asleep, Sleep, 32, A43
- Laudon, 2012, Tolerability, pharmacokinetic and pharmacodynamic evaluation of multiple ascending doses of Neu-P11 in insomnia patients, Sleep, 35, A221
- Lovenberg, 1999, Cloning and functional expression of the human histamine H3 receptor, Mol Pharmacol, 55, 1101
- Neurim Pharmaceuticals (Tel-Aviv, Israel) (Press release Feb 18 2013) Neurim Pharmaceuticals announces positive Phase 2 clinical trial results of Piromelatine for the treatment of insomnia, Neurim Pharmaceuticals, Tel-Aviv, Israel
- Nilsen, 1992, Single dose pharmacokinetics of trazodone in healthy subjects, Pharmacol Toxicol, 71, 150, 10.1111/j.1600-0773.1992.tb00535.x · doi:10.1111/j.1600-0773.1992.tb00535.x
- Nilsen, 1993, Pharmacokinetics of trazodone during multiple dosing to psychiatric patients, Pharmacol Toxicol, 72, 286, 10.1111/j.1600-0773.1993.tb01651.x · doi:10.1111/j.1600-0773.1993.tb01651.x
- Robinson, 2013, Gabapentin shows promise in treating refractory insomnia in children, J Child Neurol, 28, 1618, 10.1177/0883073812463069 · doi:10.1177/0883073812463069
- Urade, 2003, Sleep regulation in adenosine A2A receptor-deficient mice, Neurology, 61, S94
- Vanda Pharmaceuticals Inc. (Press release, June 26, 2008) Phase III data show Vanda Pharmaceuticals’ tasimelteon (VEC-162) significantly improves sleep in patients with chronic insomnia, Vanda Pharmaceuticals, Rockville, MD
Cited by
Sleep deficiency and chronic pain: potential underlying mechanisms and clinical implications
Haack, M., Simpson, N., Sethna, N., Kaur, S., & Mullington, J. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0439-z · Cited by 641
Perlis, M. L., Posner, D., Riemann, D., Bastien, C. H., Teel, J., & Thase, M. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00879-0 · Cited by 395
Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease
Chitimus, D. M., Popescu, M. R., Voiculescu, S. E., Panaitescu, A. M., Pavel, B., Zagrean, L., & Zagrean, A.-M. (2020) · Biomolecules · doi:10.3390/biom10091211 · Cited by 354
Jones, B. E. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0444-2 · Cited by 261
Schifano, F., Chiappini, S., Corkery, J. M., & Guirguis, A. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz007 · Cited by 194
Metadata
- Authors
- Atkin, T., Comai, S., & Gobbi, G.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 70
- Issue
- 2
- Pages
- 197-245
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2788590302
- Cited by
- 391
- References
- 284
- FWCI
- 38.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.